
NASDAQHealthcareMedical - Instruments & Supplies
最新データ
$80.69
+$1.05 · +1.32%
Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi. The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque. Another offering is radiopaque tape, a medical-grade adhesive applied externally to help interventionists precisely cross-reference skin locations with underlying anatomical features like vessels or lesions. Further products include valvulotomes, instruments used to cut or disrupt valves within the saphenous vein, enabling it to function as an arterial bypass to carry blood past diseased arteries to the lower leg or foot. Additionally, LeMaitre supplies vascular grafts for bypassing or replacing compromised arteries. Moreover, the company provides vascular and cardiac patches for post-surgical vessel closure. Its closure systems employ titanium clips for connecting vessels, offering an alternative to traditional sutures. Products are distributed via both its direct sales force and a network of distributors. Founded in 1983 as Vascutech, Inc., the company rebranded as LeMaitre Vascular, Inc. in April 2001. It is headquartered in Burlington, Massachusetts.
前日終値
$80.69
+$1.05 · +1.32%
日中の時刻はETです。市場データは遅延する場合があります。
Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi. The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque. Another offering is radiopaque tape, a medical-grade adhesive applied externally to help interventionists precisely cross-reference skin locations with underlying anatomical features like vessels or lesions. Further products include valvulotomes, instruments used to cut or disrupt valves within the saphenous vein, enabling it to function as an arterial bypass to carry blood past diseased arteries to the lower leg or foot. Additionally, LeMaitre supplies vascular grafts for bypassing or replacing compromised arteries. Moreover, the company provides vascular and cardiac patches for post-surgical vessel closure. Its closure systems employ titanium clips for connecting vessels, offering an alternative to traditional sutures. Products are distributed via both its direct sales force and a network of distributors. Founded in 1983 as Vascutech, Inc., the company rebranded as LeMaitre Vascular, Inc. in April 2001. It is headquartered in Burlington, Massachusetts.
日中レンジ
現在 $80.69
52週レンジ
現在 $80.69
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
買い
バリュエーション
71
割安
センチメント
71
強気
リスク
31
中程度のリスク
モメンタム
60
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi. The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque. Another offering is radiopaque tape, a medical-grade adhesive applied externally to help interventionists precisely cross-reference skin locations with underlying anatomical features like vessels or lesions. Further products include valvulotomes, instruments used to cut or disrupt valves within the saphenous vein, enabling it to function as an arterial bypass to carry blood past diseased arteries to the lower leg or foot. Additionally, LeMaitre supplies vascular grafts for bypassing or replacing compromised arteries. Moreover, the company provides vascular and cardiac patches for post-surgical vessel closure. Its closure systems employ titanium clips for connecting vessels, offering an alternative to traditional sutures. Products are distributed via both its direct sales force and a network of distributors. Founded in 1983 as Vascutech, Inc., the company rebranded as LeMaitre Vascular, Inc. in April 2001. It is headquartered in Burlington, Massachusetts.
日中レンジ
現在 $80.69
52週レンジ
現在 $80.69
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 2.5億 USD | 2.2億 USD | 1.93億 USD | 1.62億 USD | 1.54億 USD |
| 売上原価 | 7106.3万 USD | 6896.2万 USD | 6643.5万 USD | 5675.5万 USD | 5304.2万 USD |
| 粗利益 | 1.79億 USD | 1.51億 USD | 1.27億 USD | 1.05億 USD | 1.01億 USD |
| 研究開発 | 1413.9万 USD | 1565万 USD | 1696.6万 USD | 1329.4万 USD | 1180.1万 USD |
| 販売・一般管理 | 9648.8万 USD | 8299.5万 USD | 7288.6万 USD | 6166.6万 USD | 5315.6万 USD |
| 営業費用 | 1.11億 USD | 9864.5万 USD | 9033.7万 USD | 7806.7万 USD | 6495.7万 USD |
| 受取利息 | 1309.4万 USD | 494.9万 USD | 307.7万 USD | 98.6万 USD | 19.7万 USD |
| 支払利息 | 518.4万 USD | 20.5万 USD | — | — | 221.9万 USD |
| 減価償却費と償却費 | 1041.8万 USD | 967万 USD | 951.5万 USD | 943.3万 USD | 1107万 USD |
| 営業利益 | 6791.2万 USD | 5225.6万 USD | 3671.2万 USD | 2682.9万 USD | 3642.5万 USD |
| 純利益 | 5773.4万 USD | 4403.8万 USD | 3010.5万 USD | 2063.6万 USD | 2690.7万 USD |
会社概要が更新されました 2026年10月11日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
この株式へのエクスポージャーを報告している上場投資信託です。
First Trust SMID Cap Rising Dividend Achievers ETFSDVY8524.92万0.78%109.2億 USD0.58%$41.24+0.05%
Vanguard Morningstar Total Stock Market ETFVTI5568.32万0.00%2.3兆 USD0.03%$381.94+0.63%
Guggenheim Funds Trust - Guggenheim Ultra Short Income ETFGCSH5090.08万0.22%1.46億 USD0.25%$49.85+0.02%
iShares Russell 2000 ETFIWM4559.03万0.06%787.4億 USD0.19%$278.94+0.49%
Vanguard Extended Market ETFVXF1955.81万0.02%954億 USD0.05%$235+0.80%
Guggenheim Funds Trust - Guggenheim Securitized Income ETFGISC1696.69万0.23%6790万 USD0.47%$49.2511+0.08%
iShares Russell 2000 Growth ETFIWO1607.97万0.12%139.17億 USD0.24%$356.78+0.94%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM1559.71万0.10%158.4億 USD0.03%$53.45+0.17%
First Trust SMID Cap Rising Dividend Achievers ETFSDVY
Vanguard Morningstar Total Stock Market ETFVTI
Guggenheim Funds Trust - Guggenheim Ultra Short Income ETFGCSH
iShares Russell 2000 ETFIWM
Vanguard Extended Market ETFVXF
Guggenheim Funds Trust - Guggenheim Securitized Income ETFGISC
iShares Russell 2000 Growth ETFIWO
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSMAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。